Vincerx Pharma, Inc. Accumulated Other Comprehensive Income
Vincerx Pharma, Inc. had Accumulated Other Comprehensive Income of $170.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2025-05-15
- 2025-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $170.00K.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $119.00K.
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $104.00K.
- 2024-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $24.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-03-31 | $170.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $119.00K 10-Q · filed 2025-05-15 |
| 2024-09-30 | $104.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $24.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $60.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $8.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $52.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $69.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $35.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$26.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | -$63.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $4.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$6.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$21.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | -$19.00K 10-Q · filed 2021-11-12 |